Cerus Corporation Announces First Quarter 2024 Financial Results [Yahoo! Finance]
Cerus Corporation (CERS)
Last cerus corporation earnings: 2/20 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
cerus.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
CONCORD, Calif., May 02, 2024 BUSINESS WIRE )--Cerus Corporation (Nasdaq: CERS) today announced financial results for the first quarter ended March 31, 2024. Recent highlights include: First-quarter 2024 total revenue was comprised of ( in thousands, except %) Three Months Ended March 31, Change Product Revenue Government Contract Revenue Total Revenue U.S. ReCePI Phase 3 clinical trial successfully met primary endpoint for INTERCEPT Blood System for Red Blood Cells in cardiovascular surgery patients. Received FDA approval of extended shelf life for INTERCEPT Platelet Processing Sets to 12 months, doubling the previous shelf life. Advanced the LED illuminator program towards the Company's target commercial launch in the EU in 2025. Cash and cash equivalents and short-term investments were $72.2 million at March 31, 2024. The Company is reiterating its full-year 2024 annual product revenue guidance range of $172 million to $175 million. Included in this range
Show less
Read more
Impact Snapshot
Event Time:
CERS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CERS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CERS alerts
High impacting Cerus Corporation news events
Weekly update
A roundup of the hottest topics
CERS
News
- Cerus Co. (NASDAQ: CERS) had its price target raised by analysts at Cantor Fitzgerald from $3.00 to $4.00. They now have an "overweight" rating on the stock.MarketBeat
- Cerus Corporation (NASDAQ:CERS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Cerus GAAP EPS of -$0.05 in-line, revenue of $43.4M beats by $5.05M [Seeking Alpha]Seeking Alpha
- Cerus Corporation Announces First Quarter 2024 Financial ResultsBusiness Wire
- ImmuneSensor Therapeutics Appoints Veteran Biopharma Executive, Thomas W. Dubensky, Jr., Ph.D., as Chief Executive Officer [Yahoo! Finance]Yahoo! Finance
CERS
Earnings
- 5/2/24 - Miss
CERS
Sec Filings
- 5/14/24 - Form 4
- 5/13/24 - Form 4
- 5/10/24 - Form 4
- CERS's page on the SEC website